-
Add to Calendar
| Session Title | Start Time | End Time |
|---|---|---|
|
Lifting the Curtain on R&D to Advance New Drug Targets Faster
Science is driven by reproducible experimental evidence under peer-review toward global consensus, and itβs full of trial-and-error. There has been a push by some to make that research β successes and failures β more transparent to prevent others from making the same mistakes or going after the wrong targets. What can our innovation ecosystem do to share findings widely, challenge engrained beliefs, and follow new avenues, all while preserving a competitive advantage that academic and industry research require? |
8/26/2020 11:30 AM | 8/26/2020 12:00 PM |
|
Realities of Precision Medicine β How Small is Too Small?
The world of precision medicine has evolved dramatically over the years, with targeted treatment for specific patients dating back 2,500 years to Hippocrates. Although genetic and biomarker testing to guide treatment is possible, and in theory should improve care while lowering costs, barriers to widespread adoption remain. Hear from expert panelists as they offer competing views on the shifting paradigm, from biohackers and ultra-rare disease, to more mainstream targeting. How small is too small? |
8/26/2020 1:00 PM | 8/26/2020 1:30 PM |
|
AI and Drug Discovery: Marrying Data Science with Core Biology
Machine learning and model-based drug discovery is rapidly becoming the norm. Computational biology is now integrating 'wet' in vitro/in vivo and 'dry' insilico biology accelerating and saving time and resources, at least in the early stages of drug discovery. This panel will explore the new world of digital biology as a way to model potential drug effects more accurately and quickly. |
8/27/2020 10:15 AM | 8/27/2020 10:45 AM |
